A look at this week's top stories.
A study published in the journal Sleep and Breathing found sleep quality influenced newborn weight in a gender-specific and trimester-specific way.
A review of the risks, benefits, and indications for appropriate referral of fetal echocardiography
An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.
Understanding the effects is imperative for patient satisfaction.
In an effort to identify abnormal bleeding patterns and their prevalence and confirm existing and expected associations, a study was conducted as part of Apple’s larger Women’s Health Study.
Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.
Women in the late reproductive stage may experience menopause-related symptoms that could impact their quality of life, according to new research.
Labels of Plan B One-Step had previously stated—without scientific evidence—that the pill might block fertilized eggs from implanting in the womb.
The Food and Drug Administration (FDA) has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More